Agenus to Participate in Leerink Partners Global Biopharma Conference
26 Febbraio 2024 - 1:30PM
Business Wire
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering
and developing novel immunological agents to treat various cancers,
today announced that Dr. Garo Armen, Chairman and CEO, will
participate in a fireside chat and investor one-on-ones at the
upcoming Leerink Global Biopharma Conference on March 11th - 13th
in Miami Beach, Florida. The fireside chat will take place at 2:30
p.m. ET on March 11th.
A live webcast and replay of the fireside chat will be
accessible on the company’s website at
https://investor.agenusbio.com/events-and-presentations.
About Agenus
Agenus is a leading immuno-oncology company targeting cancer and
infectious diseases with a comprehensive pipeline of immunological
agents. The company’s mission is to expand patient populations
benefiting from cancer immunotherapy through combination
approaches, using a broad repertoire of antibody therapeutics,
adoptive cell therapies (through MiNK Therapeutics) and adjuvants
(through SaponiQx). Agenus is headquartered in Lexington, MA. For
more information, visit www.agenusbio.com or @agenus_bio.
Information that may be important to investors will be routinely
posted on our website and social media channels.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240226680978/en/
Investors 917-362-1370
investor@agenusbio.com
Media 781-674-4784
communications@agenusbio.com
Grafico Azioni Agenus (NASDAQ:AGEN)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Agenus (NASDAQ:AGEN)
Storico
Da Mag 2023 a Mag 2024